Pfizer Returns To Fray In Pharma Group's Wyeth Suit
Pfizer Inc. is again trying to fend off a lawsuit by a group of California pharmacies and pharmacists claiming the drugmaker's $68 billion buyout of rival Wyeth will eliminate competition and...To view the full article, register now.
Already a subscriber? Click here to view full article